Cargando…

NK Cell-Based Immunotherapy in Renal Cell Carcinoma

Natural killer (NK) cells are cytotoxic lymphocytes that are able to kill tumor cells without prior sensitization. It has been shown that NK cells play a pivotal role in a variety of cancers, highlighting their relevance in tumor immunosurveillance. NK cell infiltration has been reported in renal ce...

Descripción completa

Detalles Bibliográficos
Autores principales:	Terrén, Iñigo, Orrantia, Ane, Mikelez-Alonso, Idoia, Vitallé, Joana, Zenarruzabeitia, Olatz, Borrego, Francisco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7072691/ https://www.ncbi.nlm.nih.gov/pubmed/32013092 http://dx.doi.org/10.3390/cancers12020316

Ejemplares similares

NK Cell Metabolism and Tumor Microenvironment
por: Terrén, Iñigo, et al.
Publicado: (2019)

Metabolic changes of Interleukin-12/15/18-stimulated human NK cells
por: Terrén, Iñigo, et al.
Publicado: (2021)

Implication of Interleukin-12/15/18 and Ruxolitinib in the Phenotype, Proliferation, and Polyfunctionality of Human Cytokine-Preactivated Natural Killer Cells
por: Terrén, Iñigo, et al.
Publicado: (2018)

Identification and Functional Analysis of Human CD56(neg) NK Cells by Flow Cytometry
por: Orrantia, Ane, et al.
Publicado: (2020)

Human NK Cells in Autologous Hematopoietic Stem Cell Transplantation for Cancer Treatment
por: Orrantia, Ane, et al.
Publicado: (2021)

The Expression and Function of CD300 Molecules in the Main Players of Allergic Responses: Mast Cells, Basophils and Eosinophils
por: Vitallé, Joana, et al.
Publicado: (2020)

Cytokine-Induced Memory-Like NK Cells: From the Basics to Clinical Applications
por: Terrén, Iñigo, et al.
Publicado: (2022)

Increased expression levels of CD300c on basophils from allergic individuals()
por: Vitallé, Joana, et al.
Publicado: (2019)

CD300a inhibits CD16-mediated NK cell effector functions in HIV-1-infected patients
por: Vitallé, Joana, et al.
Publicado: (2019)

A NKp80-Based Identification Strategy Reveals that CD56(neg) NK Cells Are Not Completely Dysfunctional in Health and Disease
por: Orrantia, Ane, et al.
Publicado: (2020)

Polyfunctional HIV-1 specific response by CD8+ T lymphocytes expressing high levels of CD300a
por: Vitallé, Joana, et al.
Publicado: (2020)

Increased Frequency of CTLA-4 and PD-1 Expressing Regulatory T Cells and Basophils With an Activating Profile in Infants With Moderate-to-Severe Atopic Dermatitis Hypersensitized to Food Allergens
por: Bilbao, Agurtzane, et al.
Publicado: (2021)

Altered Expression of CD300a Inhibitory Receptor on CD4+ T Cells From Human Immunodeficiency Virus-1-Infected Patients: Association With Disease Progression Markers
por: Vitallé, Joana, et al.
Publicado: (2018)

NK Cell Reconstitution After Autologous Hematopoietic Stem Cell Transplantation: Association Between NK Cell Maturation Stage and Outcome in Multiple Myeloma
por: Orrantia, Ane, et al.
Publicado: (2021)

Human IgM(hi)CD300a(+) B Cells Are Circulating Marginal Zone Memory B Cells That Respond to Pneumococcal Polysaccharides and Their Frequency Is Decreased in People Living with HIV
por: Vitallé, Joana, et al.
Publicado: (2023)

Monocytes Phenotype and Cytokine Production in Human Immunodeficiency Virus-1 Infected Patients Receiving a Modified Vaccinia Ankara-Based HIV-1 Vaccine: Relationship to CD300 Molecules Expression
por: Vitallé, Joana, et al.
Publicado: (2017)

In vivo expansion of a CD9(+) decidual-like NK cell subset following autologous hematopoietic stem cell transplantation
por: Orrantia, Ane, et al.
Publicado: (2022)

IL-12/15/18-induced cell death and mitochondrial dynamics of human NK cells
por: Terrén, Iñigo, et al.
Publicado: (2023)

T Cell Activation, Highly Armed Cytotoxic Cells and a Shift in Monocytes CD300 Receptors Expression Is Characteristic of Patients With Severe COVID-19
por: Zenarruzabeitia, Olatz, et al.
Publicado: (2021)

The expression and function of human CD300 receptors on blood circulating mononuclear cells are distinct in neonates and adults
por: Zenarruzabeitia, Olatz, et al.
Publicado: (2016)

Natural Killer Cells for Cancer Immunotherapy: Pluripotent Stem Cells-Derived NK Cells as an Immunotherapeutic Perspective
por: Eguizabal, Cristina, et al.
Publicado: (2014)

Cancer Nano-Immunotherapy from the Injection to the Target: The Role of Protein Corona
por: Mikelez-Alonso, Idoia, et al.
Publicado: (2020)

Editorial: NK Cell-Based Cancer Immunotherapy
por: Borrego, Francisco, et al.
Publicado: (2016)

CD300c is uniquely expressed on CD56(bright) Natural Killer Cells and differs from CD300a upon ligand recognition
por: Dimitrova, Milena, et al.
Publicado: (2016)

A Human Anti-M2 Antibody Mediates Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC) and Cytokine Secretion by Resting and Cytokine-Preactivated Natural Killer (NK) Cells
por: Simhadri, Venkateswara R., et al.
Publicado: (2015)

Turning universal O into rare Bombay type blood
por: Anso, Itxaso, et al.
Publicado: (2023)

The Function of NK Cells in Tumor Metastasis and NK Cell-Based Immunotherapy
por: Yu, Yanlin
Publicado: (2023)

NK Cell-Based Glioblastoma Immunotherapy
por: Golán, Irene, et al.
Publicado: (2018)

NK Cell-Based Immunotherapies in Cancer
por: Shin, Min Hwa, et al.
Publicado: (2020)

NK cell-based tumor immunotherapy
por: Zhang, Hao, et al.
Publicado: (2023)

Natural killer cell dysfunction in hepatocellular carcinoma and NK cell-based immunotherapy
por: Sun, Cheng, et al.
Publicado: (2015)

T and NK Cell-Based Immunotherapy in Chronic Viral Hepatitis and Hepatocellular Carcinoma
por: Fisicaro, Paola, et al.
Publicado: (2022)

NK Cell-Based Immunotherapy in Cancer Metastasis
por: Lorenzo-Herrero, Seila, et al.
Publicado: (2018)

NK Cell-Based Immunotherapy for Hematological Malignancies
por: Sivori, Simona, et al.
Publicado: (2019)

NK Cell-Based Immunotherapy in Colorectal Cancer
por: Della Chiesa, Mariella, et al.
Publicado: (2022)

Natural Killer Cells in Liver Disease and Hepatocellular Carcinoma and the NK Cell-Based Immunotherapy
por: Liu, Pingyi, et al.
Publicado: (2018)

Underlying mechanisms of evasion from NK cells as rationale for improvement of NK cell-based immunotherapies
por: Seliger, Barbara, et al.
Publicado: (2022)

NK cell-based immunotherapy for treating cancer: will it be promising?
por: Cho, Duck, et al.
Publicado: (2011)

Technical advances in NK cell-based cellular immunotherapy
por: Fang, Fang, et al.
Publicado: (2019)

The Advances and Challenges of NK Cell-Based Cancer Immunotherapy
por: Kang, Synat, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ohpirav680kiin5kkd0s84htm1